Uganda Martyrs University Institutional Repository (UMU-IR)
    • Login
    View Item 
    •   UMU-IR Home
    • Research Articles
    • Faculty of Health Science
    • Journal Articles (Health)
    • View Item
    •   UMU-IR Home
    • Research Articles
    • Faculty of Health Science
    • Journal Articles (Health)
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Treatment with anthelminthics during pregnancy: what gains and what risks for the mother and child?

    Thumbnail
    View/Open
    Ndibazza_Health_Article_2011_D.pdf (234.9Kb)
    Date
    2011
    Author
    Elliott, Alison M
    Ndibazza, Juliet
    Mpairwe, Harriet
    Muhangi, Lawrence
    Webb, Emily L
    Kizito, Dennison
    Mawa, Patrice A
    Tweyongyere, Robert
    Muwanga, Moses
    Metadata
    Show full item record
    Abstract
    In 1994 and 2002, respectively, theWorld Health Organisation proposed that treatment for hookworm and schistosomiasis could be provided during pregnancy. It was hoped that this might have benefits for maternal anaemia, fetal growth and perinatal mortality; a beneficial effect on the infant response to immunisation was also hypothesised. Three trials have now been conducted. Two have examined the effects of benzimidazoles; one (the Entebbe Mother and Baby Study) the effects of albendazole and praziquantel. All three were conducted in settings of high prevalence but low intensity helminth infection. Results suggest that, in such settings and given adequate provision of haematinics, the benefit of routine anthelminthics during pregnancy for maternal anaemia may be small; none of the other expected benefits has yet been demonstrated. The Entebbe Mother and Baby Study found a significant adverse effect of albendazole on the incidence of infantile eczema in the whole study population, and of praziquantel on the incidence of eczema among infants of mothers with Schistosoma mansoni. Further studies are required in settings that differ in helminth species and infection intensities. Further research is required to determine whether increased rates of infantile eczema translate to long-term susceptibility to allergy, and to explore the underlying mechanisms of these effects. The risks and benefits of routine anthelminthic treatment in antenatal clinics may need to be reconsidered.
    URI
    http://hdl.handle.net/20.500.12280/554
    Collections
    • Journal Articles (Health) [150]

    UMU-IR
    Contact Us | Send Feedback | Library | Library Catalogue
    Atmire NV
     

     

    Browse

    UMU-IRCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    UMU-IR
    Contact Us | Send Feedback | Library | Library Catalogue
    Atmire NV